Michel Lazdunski

Source: Wikipedia, the free encyclopedia.

Michel Lazdunski
Born (1938-04-11) 11 April 1938 (age 86)
EducationÉcole nationale supérieure de chimie de Clermont-Ferrand, Laval University (PhD chemistry-physics, 1962), University of Marseille (PhD biochemistry, 1964)
Known forIon channels
AwardsFrench Academy of sciences, CNRS Silver Medal
Scientific career
FieldsBiochemistry
InstitutionsCNRS, Nice/Sophia Antipolis
Doctoral advisorLudovic Ouellet

Michel Lazdunski (born 11 April 1938, in Marseille) is a French biologist specializing in biochemistry, physiology, pathophysiology, molecular pharmacology and neuroscience.[1]

Biography

Michel Lazdunski is a

University of Nice in 1968. He founded the CNRS Biochemistry Centre there, which he managed until 1989, when he moved to the Sophia Antipolis science park to direct the CNRS Institute of Molecular and Cellular Pharmacology, which he had just created and which he managed until 2004. During his academic career in Nice/Sophia Antipolis, he was successively Professor of Biochemistry (Faculty of Sciences), Director of Research seconded to the CNRS and Professor of Pharmacology PU-PH (Faculty of Medicine).Michel Lazdunski was a member of the Scientific Council (1997–2001) and the Board of Directors (2001–2005) of the CNRS and the Council of the European Molecular Biology Organisation (1990–1995). He has chaired many committees including the UNECE Life Sciences Committee (Human Capital and Mobility Programme 1996–1997) and the National Coordinating Committee for Life Sciences (2001–2002).[citation needed
]

He was elected a full member of the French Academy of sciences in 1991.[2] He was appointed senior member of the Institut universitaire de France in 1991 for a five-year term,[3] renewed in 1996.[4]

Scientific contribution

The first part of Michel Lazdunski's scientific career (awarded the

polyunsaturated fatty acids of the ɯɜ type. TREK channels play a central role in depression.[9] The TASK and TREK channels are a major therapeutic target for gaseous anesthetics.[5][6][10]

Previously, Michel Lazdunski and his team had made pioneering discoveries on the CFTR[5][11] channel associated with cystic fibrosis, which indicated the direction to follow for current therapeutic developments on some forms of this genetic disease.

References

  1. ^ "Université côte d'Azur".
  2. ^ "Académie des sciences".
  3. ^ "Arrêté du 2 décembre 1991 portant nomination à l'Institut universitaire de France". Legifrance. Retrieved 8 March 2020.
  4. ^ "Arrêté du 8 août 1996 portant nomination des membres seniors et juniors de l'Institut universitaire de France". Legifrance. Retrieved 8 March 2020.
  5. ^ a b c d e "Michel Lazdunski-Research gate".
  6. ^ a b c d Michel Lazdunski publications indexed by Google Scholar
  7. PMID 2305257
    .
  8. .
  9. .
  10. .
  11. .